[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know",
    "summary": "Vertex Pharmaceuticals (VRTX) reachead $509.47 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.",
    "url": "https://finnhub.io/api/news?id=383b5bc12e59ce6297434a16d40c2a7581109c97ff8a9f8a979c73ebcc8078ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746049817,
      "headline": "Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know",
      "id": 134166126,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (VRTX) reachead $509.47 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=383b5bc12e59ce6297434a16d40c2a7581109c97ff8a9f8a979c73ebcc8078ca"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Growth Fund Q1 2025 Commentary",
    "summary": "ClearBridge Growth Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=56c76447ce5b6ed0706c2165274a81d9d82a538391b62848956b24d7c420fe39",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746048900,
      "headline": "ClearBridge Growth Fund Q1 2025 Commentary",
      "id": 134165019,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=56c76447ce5b6ed0706c2165274a81d9d82a538391b62848956b24d7c420fe39"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=da865df1c649477720c15a567d2f72216be043471be1593a56b34bff77619ba1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746030960,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 134190903,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=da865df1c649477720c15a567d2f72216be043471be1593a56b34bff77619ba1"
    }
  },
  {
    "ts": null,
    "headline": "What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings",
    "summary": "Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vertex (VRTX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.",
    "url": "https://finnhub.io/api/news?id=8473845736bfc55314c3e7cb2025d5ebe2c3739104163b301f9eba988ff8968a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746018920,
      "headline": "What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings",
      "id": 134166127,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vertex (VRTX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.",
      "url": "https://finnhub.io/api/news?id=8473845736bfc55314c3e7cb2025d5ebe2c3739104163b301f9eba988ff8968a"
    }
  },
  {
    "ts": null,
    "headline": "The Davenport Core Leaders Fund Q1 2025 Commentary",
    "summary": "The Davenport Core Leaders Fund declined 3.48% in Q1 2025, although it did exceed its benchmark. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=30cbbdae87c9b1b956e51ece59c8a96cf5c63ad9d62c5732ec1a96c345d1f8cc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746008100,
      "headline": "The Davenport Core Leaders Fund Q1 2025 Commentary",
      "id": 134145301,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1385970223/image_1385970223.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The Davenport Core Leaders Fund declined 3.48% in Q1 2025, although it did exceed its benchmark. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=30cbbdae87c9b1b956e51ece59c8a96cf5c63ad9d62c5732ec1a96c345d1f8cc"
    }
  }
]